Catalyst Wire Dossier Catalyst Wire Dossier

Sugammadex Fresenius Kabi

Sugammadex · Fresenius Kabi Deutschland GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sugammadex Fresenius Kabi, covering 2025-07-11 to 2025-07-11. Get the full timeline:

Most recent: EMA Authorised: Sugammadex Fresenius Kabi (sugammadex sodium) — Fresenius Kabi Deutschland GmbH

See pricing